Endothelial Progenitor Cell Technology

Coronary stent technology development trends include the stimulation of vessel wall healing following revascularization.

OrbusNeich has developed its "Genous", a patented endothelial progenitor cell (EPC) capture technology designed and shown to promote the accelerated natural healing of the vessel wall following stenting.
 
See link on OrbusNeich Genous recent data.


The MedMarket Diligence report #C245 covers the global market for the full range of coronary stents on the market and under development.

Leave a Reply